Moleculin Biotech, Inc. — Director's Dealing 2016

Jun 8, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2016-06-02

Reporting Person: KLEMP WALTER V (Director, Chairman and Acting CEO, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1055724	Direct
Common Stock	1075000	Indirect

Footnotes

F1: Annamed, Inc. holds 1,425,000 shares of Issuer common stock. The reporting person is the majority shareholder and control person of Annamed, Inc. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc.